(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 4.61% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.72%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.87%.
Anika Therapeutics's revenue in 2026 is $120,654,000.On average, 4 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,668,588,201, with the lowest ANIK revenue forecast at $1,598,729,118, and the highest ANIK revenue forecast at $1,722,521,554. On average, 4 Wall Street analysts forecast ANIK's revenue for 2027 to be $1,754,908,332, with the lowest ANIK revenue forecast at $1,673,539,898, and the highest ANIK revenue forecast at $1,819,949,546.
In 2028, ANIK is forecast to generate $1,879,102,256 in revenue, with the lowest revenue forecast at $1,805,495,943 and the highest revenue forecast at $1,934,373,906.